✦ LIBER ✦

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

✍ Scribed by Hurwitz, Herbert; Fehrenbacher, Louis; Novotny, William; Cartwright, Thomas; Hainsworth, John; Heim, William; Berlin, Jordan; Baron, Ari; Griffing, Susan; Holmgren, Eric; Ferrara, Napoleone; Fyfe, Gwen; Rogers, Beth; Ross, Robert; Kabbinavar, Fairooz

Book ID: 120216780
Publisher: Massachusetts Medical Society
Year: 2004
Tongue: English
Weight: 103 KB
Volume: 350
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa032691

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in combination with irinotec

Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancer: Abstracted from: Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335–42

✍ Michael A. Choti 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Bevacizumab plus irinotecan, 5-fluoroura

Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study

✍ Deng, Ting; Zhang, Le; Liu, Xiao-jian; Xu, Jian-ming; Bai, Yu-xian; Wang, Yan; H 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 199 KB

Irinotecan plus Fluorouracil and Leucovo

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

✍ Saltz, Leonard B.; Cox, John V.; Blanke, Charles; Rosen, Lee S.; Fehrenbacher, L 📂 Article 📅 2000 🏛 Massachusetts Medical Society 🌐 English ⚖ 136 KB

150 Molecular tumor characteristics and

150 Molecular tumor characteristics and response to bevacizumab plus irinotecan/5-fluorouracil/leucovorin in metastatic colorectal cancer

✍ H. Koeppen; W. Ince; E. Holmgren; M. Zhang; P. Tobin; R. Zhang; W. Novotny; K. H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 134 KB

First-line panitumumab plus irinotecan/5

First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer

✍ Claus-Henning Köhne; Ralf Hofheinz; Laurent Mineur; Henry Letocha; Richard Greil 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 584 KB

Irinotecan plus fluorouracil: first-line

Irinotecan plus fluorouracil: first-line in metastatic colorectal cancer

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB